Entacapone
NDC 0527-1830, entacapone, tablet, film coated, from Lannett Company, Inc..
- Product NDC
- 0527-1830
- Status
- Listed
- Labeler
- Lannett Company, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206669
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0527-1830 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ENTACAPONE200 mg/1
Pharmacologic classes
Catechol O-Methyltransferase Inhibitors [MoA]; Catechol-O-Methyltransferase Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0527-1830-37 | 00527183037 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0527-1830-37) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0bf133e4-1c17-4358-9a43-144e6bf2564fNADAC price for package 00527183037
GET /v1/drugs/nadac/00527183037
Use it
Look up 0527-1830 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0527-1830 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0527-1830. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.